119 related articles for article (PubMed ID: 11239012)
21. Classical and novel retinoids: their targets in cancer therapy.
Fontana JA; Rishi AK
Leukemia; 2002 Apr; 16(4):463-72. PubMed ID: 11960323
[TBL] [Abstract][Full Text] [Related]
22. Hematopoiesis and retinoids: development and disease.
Oren T; Sher JA; Evans T
Leuk Lymphoma; 2003 Nov; 44(11):1881-91. PubMed ID: 14738139
[TBL] [Abstract][Full Text] [Related]
23. [Retinoids: mechanisms of action].
Berbis P
Ann Dermatol Venereol; 2010 Nov; 137 Suppl 3():S97-103. PubMed ID: 21185985
[TBL] [Abstract][Full Text] [Related]
24. [Current knowledge on the action of retinoids in carcinoma of the head and neck].
Dolivet G; Ton Van J; Sarini J; Wattel E; Lagarde P; Chomy F; Lefebvre JL
Rev Laryngol Otol Rhinol (Bord); 1996; 117(1):19-26. PubMed ID: 8734261
[TBL] [Abstract][Full Text] [Related]
25. [Retinoids in oncology].
Kiemle-Kallee J; Porzsolt F
Dtsch Med Wochenschr; 1993 Mar; 118(11):390-4. PubMed ID: 8384099
[No Abstract] [Full Text] [Related]
26. [Vitamin A and retinoids. From natural products to potent drugs].
Vahlquist A
Lakartidningen; 1993 Sep; 90(38):3182, 3185-8. PubMed ID: 8231470
[No Abstract] [Full Text] [Related]
27. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
[TBL] [Abstract][Full Text] [Related]
28. The retinoid receptors.
Pemrick SM; Lucas DA; Grippo JF
Leukemia; 1994 Nov; 8(11):1797-806. PubMed ID: 7967725
[TBL] [Abstract][Full Text] [Related]
29. Regulation of lipid and lipoprotein metabolism by retinoids.
Staels B
J Am Acad Dermatol; 2001 Nov; 45(5):S158-67. PubMed ID: 11606948
[TBL] [Abstract][Full Text] [Related]
30. Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat.
Schaier M; Liebler S; Schade K; Shimizu F; Kawachi H; Grone HJ; Chandraratna R; Ritz E; Wagner J
J Mol Med (Berl); 2004 Feb; 82(2):116-25. PubMed ID: 14712350
[TBL] [Abstract][Full Text] [Related]
31. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids.
Haugen BR; Larson LL; Pugazhenthi U; Hays WR; Klopper JP; Kramer CA; Sharma V
J Clin Endocrinol Metab; 2004 Jan; 89(1):272-80. PubMed ID: 14715861
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional activities of retinoic acid receptors.
Lefebvre P; Martin PJ; Flajollet S; Dedieu S; Billaut X; Lefebvre B
Vitam Horm; 2005; 70():199-264. PubMed ID: 15727806
[TBL] [Abstract][Full Text] [Related]
33. [Expression of retinoic acid receptors in head and neck squamous cell carcinomas and their possible implication for chemoprevention].
Issing WJ
Laryngorhinootologie; 2001 Sep; 80(9):530-4. PubMed ID: 11555786
[TBL] [Abstract][Full Text] [Related]
34. Retinoids and rexinoids in cancer prevention: from laboratory to clinic.
Uray IP; Dmitrovsky E; Brown PH
Semin Oncol; 2016 Feb; 43(1):49-64. PubMed ID: 26970124
[TBL] [Abstract][Full Text] [Related]
35. Retinoids: a journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects.
Khalil S; Bardawil T; Stephan C; Darwiche N; Abbas O; Kibbi AG; Nemer G; Kurban M
J Dermatolog Treat; 2017 Dec; 28(8):684-696. PubMed ID: 28318351
[TBL] [Abstract][Full Text] [Related]
36. Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities.
Lefebvre P
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):153-64. PubMed ID: 12476796
[TBL] [Abstract][Full Text] [Related]
37. Expression of retinoic acid receptors in squamous cell carcinomas and their possible implication for chemoprevention.
Issing WJ; Wustrow TP
Anticancer Res; 1996; 16(4C):2373-7. PubMed ID: 8816837
[TBL] [Abstract][Full Text] [Related]
38. Retinoids in lung cancer: friend, foe, or fellow traveler?
Khuri FR; Lotan R
J Clin Oncol; 2004 Sep; 22(17):3435-7. PubMed ID: 15277536
[No Abstract] [Full Text] [Related]
39. Potential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferons.
Fanjul AN; Bouterfa H; Dawson M; Pfahl M
Cancer Res; 1996 Apr; 56(7):1571-7. PubMed ID: 8603404
[TBL] [Abstract][Full Text] [Related]
40. Cytodifferentiation by retinoids, a novel therapeutic option in oncology: rational combinations with other therapeutic agents.
Garattini E; Gianni' M; Terao M
Vitam Horm; 2007; 75():301-54. PubMed ID: 17368321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
